Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07306182) titled 'A Research Study to Evaluate the Efficacy and Safety of SGC001 in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction' on Dec. 24, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Sungen Biomedical Technology Co., Ltd
Condition:
Anterior Myocardial Infarction
Intervention:
Drug: SGC001
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: February 2026
Target Sample Siz...